- Natural human CD4+CD25+FOXP3+ T regulatory cells isolated from PBMCs
- Confirmed suppressive capacity
- Used for a wide variety of in-vitro applications, including co-culture suppression and cytotoxicity assays
- Carefully cryopreserved to ensure high viability (> 80%) upon thawing
- All orders come with an iQ Certificate of Analysis
- Normally ships out same business day
Human CD4+CD25+FOXP3+ Natural T Regulatory Cells
Human CD4+CD25+FOXP3+ T Regulatory Cells
Human T regulatory cells (Treg cells) are characterized as CD4+ lymphocytes cells that can down-regulate the activity of T cells, B cells, NK cells, and macrophages. Their suppressive function in lymphoid and non-lymphoid tissues help to establish and maintain tolerance to prevent autoimmunity and hyper-activation in inflammatory responses. Numerous studies have demonstrated the role of Treg cells in the development of autoimmune diseases and efforts are underway to target them with therapeutics to treat these diseases.
Recent studies have also shown that Tregs can infiltrate and develop in the tumor environment. Ovarian, renal, and colon cancers are among the human cancers that have been linked to increased Tregs. Not surprisingly, poor prognosis is associated with an increase in the number of these cells. With these emerging findings, researchers are developing therapeutics that specifically target Tregs to eliminate them from the tumor environment so that remaining lymphocytes can become activated and target tumor cells.
Treg cells come in various subtypes and can develop in the thymus or periphery. Those that develop in the thymus are called Natural Tregs (nTregs), while those that develop in the periphery and tumor are termed Induced Tregs (iTregs). Both nTregs and iTregs express the surface proteins CD4 and CD25, as well as the transcription factor FOXP3. An additional criteria to identify both types of Tregs is the low expression of CD127, the IL-7 receptor.
While both nTregs and iTregs are identified using similar markers, they are thought to have different roles in health and disease. The nTregs are believed to maintain peripheral tolerance to prevent autoimmunity and immune system hyper-responsiveness. In contrast, iTregs are thought to develop from conventional T cells in a suppressive tumor environment. In addition to an already suppressive cytokine environment, the presence of iTregs makes the tumor environment even more potent in preventing lymphocytes from attacking the tumor. More so, it has been shown that iTregs have more suppressive capabilities than nTregs, making them more robust regulators of lymphocyte function.
Tregs can suppress lymphocyte function through multiple mechanisms. They can secrete immuno-suppressive factors, such as IL-10 and TGF-b, to prevent the activation or down-regulate the activity of lymphocytes. They may also work by being an “IL-2 sink” in which the high expression of the IL-2 receptor on Tregs bind the local concentrated amount of IL-2 to prevent it from binding lymphocytes to drive an inflammatory response. In addition, Tregs may express checkpoint proteins, such as CTLA-4 and PD-L1, to act through cell-cell contact. Finally, some data suggest that iTregs may utilize multiple mechanisms to suppress lymphocyte function, which is consistent with the observation they are more potent than nTregs.
Application Summary for Natural T Regulatory (nTreg) Cells
Natural Tregs are a good source of cells to study the function of Tregs in an in vitro setting, in particular co-culture suppression assays. Here, Tregs are co-cultured with lymphocytes and then assayed for lymphocyte proliferation and cytokine release. In the presence of Tregs, lymphocyte function should be down-regulated.
With the current trend towards development of molecules that modulate the immune system to treat cancer and autoimmune diseases, these co-culture assays are also commonly used to test whether a potential therapeutic can inhibit or promote Treg function. Further, because Tregs are difficult to isolate from tissue and a great number of them are required for co-culture assays, frozen nTregs are a valuable source to enable the execution of these studies.
For some antibody-based cancer therapeutics being developed, cancer-associated iTregs are being targeted for antibody-dependent cellular cytotoxicity or complement dependent cytotoxicity. However, targeting nTregs should not be avoided in order to maintain tolerance. Therefore, frozen nTregs are also a good source of target cells for these studies interrogating cell death or the avoidance thereof.
Many questions about how nTregs develop and progress through developmental stages also remain unanswered, and frozen nTregs are a good source of cells to study this development through genetic and transcriptional profiling. DNA or RNA can easily be isolated from these cells and used for downstream applications and analysis.
Isolation of nTregs
nTregs are enriched from PBMCs of human donors using a negative selection kit and magnetic isolation. To ensure that nTregs were isolated, cells are analyzed for the expression of CD4, CD25, FOXP3, and CD127. Our frozen nTregs are a reliable and ideal source to obtain plentiful cells for your studies.
Cryopreservation and Storage
Our nTregs were cryopreserved carefully using iQ Biosciences’ cryopreservation protocol that ensures high viability (> 80%) after thawing.
Cells should be stored at < -120°C once they are received, such as within a liquid nitrogen tank (vapor phase).
Quality Control Process
We implement random sampling per lot to test for viability and cell counts to ensure they meet specifications, which are recorded on the Certificate of Analysis that is included with each shipment. Cell counts are obtained using a manual hemocytometer and then cross-referenced with an automated cell counter. Each lot is also characterized for unique cell populations by immunophenotyping, in which the results are also recorded on the Certificate of Analysis.
We are Committed to Ethical Practices
iQ Biosciences’ human primary cell products are lawfully obtained in accordance with Local, State, and Federal U.S. requirements, and the collection of cells complies with ethical requirements. Our cells are obtained from normal or disease patient volunteers participating in a donor program that is approved by an Institutional Review Board (IRB) or Human Subject Committee. A signed and witnessed consent form is obtained from donor volunteers prior to starting the collection protocol. Strict controls on personal identifiers of volunteers are in place in order to protect their privacy.
For US customers, we ship via FedEx Overnight Shipping. Shipping charges will vary per shipping address (based on ZIP code) and are estimated to be $110.
For international (non-US) customers, we work closely with you and our couriers to ensure all necessary documentation is in place for international shipments to significantly reduce the chance of delays at Customs. For the export of non-human primate samples, this includes preparing CITES permits, as well as any other documentation as required by country. Please submit an inquiry to firstname.lastname@example.org for your estimated time of delivery and shipping charges.